Oceanside, CALIFORNIA5 Active Studies

Major Depressive Disorder Clinical Trials in Oceanside, CALIFORNIA

Find 5 actively recruiting major depressive disorder clinical trials in Oceanside, CALIFORNIA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,275
Enrolling

Recruiting Major Depressive Disorder Studies in Oceanside

RecruitingOceanside, CALIFORNIANCT06775379

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants ...

450 participants
Xenon Pharmaceuticals Inc.
View Study Details
RecruitingOceanside, CALIFORNIANCT06223880

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with m...

350 participants
Axsome Therapeutics, Inc.
View Study Details
RecruitingOceanside, CALIFORNIANCT06564818

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD....

220 participants
Cybin IRL Limited
View Study Details
RecruitingOceanside, CALIFORNIANCT06836063

Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients

The primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD)....

195 participants
Suven Life Sciences Limited
View Study Details
RecruitingOceanside, CALIFORNIANCT06391593

PD, PK, and Safety of ALTO-203 in Patients With MDD

The goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment period. Additionally, ...

60 participants
Alto Neuroscience
View Study Details

About Major Depressive Disorder Clinical Trials in Oceanside

Major depressive disorder (MDD) is a severe form of depression characterized by persistent sadness, loss of interest, and impaired daily functioning. Treatment-resistant depression (TRD) affects patients who do not respond to standard therapies. Novel treatments like ketamine, psilocybin, and neuromodulation are being studied.

There are currently 5 major depressive disorder clinical trials recruiting participants in Oceanside, CALIFORNIA. These studies are seeking a combined 1,275 participants. Research is being sponsored by Xenon Pharmaceuticals Inc., Axsome Therapeutics, Inc., Cybin IRL Limited and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Major Depressive Disorder Clinical Trials in Oceanside — FAQ

Are there major depressive disorder clinical trials in Oceanside?

Yes, there are 5 major depressive disorder clinical trials currently recruiting in Oceanside, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oceanside?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oceanside research site will contact you about next steps.

Are clinical trials in Oceanside free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oceanside studies also compensate for your time and travel.

What major depressive disorder treatments are being tested?

The 5 active trials in Oceanside are testing new therapies including novel drugs, biologics, and treatment approaches for major depressive disorder.

Data updated March 2, 2026 from ClinicalTrials.gov